Perspective - (2025) Volume 10, Issue 4
Received: 01-Aug-2025, Manuscript No. jdcm-26-182208;
Editor assigned: 04-Aug-2025, Pre QC No. P-182208;
Reviewed: 18-Aug-2025, QC No. Q-182208;
Revised: 22-Aug-2025, Manuscript No. R-182208;
Published:
29-Aug-2025
, DOI: 10.37421/2475-3211.2025.10.327
Citation: Alvarez, Ricardo M.. ”Diabetes Impairs Wound Healing: Multifaceted Mechanisms Revealed.” J Diabetic Complications Med 10 (2025):327.
Copyright: © 2025 Alvarez M. Ricardo This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Diabetes mellitus is a complex chronic condition that significantly compromises the intricate process of wound healing, affecting various biological mechanisms essential for tissue repair. The persistent state of hyperglycemia, a hallmark of diabetes, triggers a cascade of detrimental events, including the formation of advanced glycation end products (AGEs), heightened oxidative stress, and chronic inflammation, all of which disrupt the natural progression of wound repair. These disruptions manifest as impaired granulation tissue formation, reduced angiogenesis, and compromised re-epithelialization, collectively delaying or preventing wound closure. Furthermore, common comorbidities associated with diabetes, such as neuropathy and peripheral artery disease, exacerbate these healing challenges by diminishing sensation and restricting blood flow, respectively, thereby increasing the susceptibility to chronic, non-healing ulcers. [1] Hyperglycemia-induced oxidative stress emerges as a primary culprit in the impaired wound healing observed in diabetic individuals. Elevated blood glucose levels drive the overproduction of reactive oxygen species (ROS), overwhelming the body's natural antioxidant defense systems. This pervasive oxidative damage inflicts harm on critical cellular components, including fibroblasts, endothelial cells, and immune cells, critically hindering their capacity to proliferate, migrate, and synthesize the extracellular matrix (ECM) components indispensable for tissue regeneration. Concurrently, the inflammatory response becomes dysregulated, fostering a state of chronic inflammation that further impedes the healing trajectory. [2] The accumulation of advanced glycation end products (AGEs) within diabetic tissues plays a pivotal role in exacerbating impaired wound healing. AGEs arise from the non-enzymatic glycation of proteins and lipids by sugars, leading to profound alterations in their structure and function. Within the context of a wound, AGEs contribute to the stiffening of collagen, impede the essential migratory and proliferative activities of wound healing cells, and promote inflammation through the activation of the receptor for advanced glycation end products (RAGE). This complex interplay disrupts the critical matrix remodeling and cellular communication necessary for effective wound closure. [3] Impaired angiogenesis, the vital process of forming new blood vessels, represents another critical factor contributing to delayed wound healing in diabetic patients. Hyperglycemia, coupled with related factors such as increased resistance to vascular endothelial growth factor (VEGF), diminishes the ability of endothelial cells to effectively migrate and establish new vascular networks. This compromised vascular supply leads to a reduction in the delivery of essential oxygen, nutrients, and inflammatory cells to the wound site, thereby decelerating all phases of the healing process. Diabetic neuropathy can further compound this issue by impairing tissue perfusion. [4] Diabetic neuropathy, characterized by the progressive damage to peripheral nerves, profoundly influences wound healing by attenuating sensory perception and autonomic nerve function. The loss of protective sensation increases the risk of unnoticed injuries, while compromised autonomic control can disrupt the regulation of blood flow and sweat gland activity. This can lead to the development of dry, brittle skin that is more susceptible to fissures and subsequent ulceration, creating a local environment that is unfavorable for the inflammatory and proliferative phases of healing. [5] The inflammatory response within diabetic wounds is notably aberrant. While acute inflammation is a necessary precursor to wound healing, the persistent and unresolved chronic inflammation characteristic of diabetes leads to ongoing tissue damage and critically inhibits the transition to the proliferative phase. Dysfunctional neutrophils and macrophages, their activity significantly influenced by hyperglycemia, contribute to this prolonged inflammatory state, hindering the clearance of cellular debris and the production of crucial growth factors required for effective tissue repair. [6] Disruptions in extracellular matrix (ECM) turnover represent another significant challenge in diabetic wound healing. Fibroblasts residing in the diabetic microenvironment exhibit altered production of ECM components and demonstrate reduced proliferative and migratory capacities. Furthermore, elevated activity of matrix metalloproteinases (MMPs), often driven by underlying inflammation and hyperglycemia, can result in excessive degradation of the ECM. This uncontrolled breakdown prevents the formation of a stable scaffold necessary for cellular organization and migration, ultimately impeding wound closure. [7] Peripheral artery disease (PAD), a prevalent complication of diabetes, exerts a substantial negative impact on wound healing by severely reducing blood flow to the extremities. The atherosclerotic process narrows the arteries, leading to chronic ischemia and a consequent deficit in oxygen and nutrient delivery to the affected tissues. Consequently, wounds in diabetic patients with PAD are particularly vulnerable to delayed healing, increased risk of infection, and a higher likelihood of requiring amputation. [8] Therapeutic interventions for diabetic wound healing are multifaceted, aiming to address the fundamental physiological dysregulations characteristic of the condition. Paramount among these is the strict control of glycemic levels. In addition to glycemic management, therapeutic strategies that effectively reduce oxidative stress, modulate the aberrant inflammatory response, promote angiogenesis, and enhance tissue perfusion are essential for successful healing. Advanced wound care modalities, such as negative pressure wound therapy, hyperbaric oxygen therapy, and the application of growth factors, are frequently integrated into treatment plans. [9] The role of the cutaneous microbiome in the context of diabetic wound healing is an increasingly important area of investigation. Alterations in the composition and balance of the skin microbiome, exacerbated by the compromised immune response inherent in diabetes, can contribute to the persistence of chronic wound infections and significantly delay healing. A deeper understanding of the microbial landscape and the development of strategies to restore a healthy microbiome may unveil novel avenues for therapeutic intervention. [10]
Diabetes mellitus imposes significant impediments on the complex process of wound healing through a variety of pathological mechanisms. The chronic elevation of blood glucose levels, a defining characteristic of diabetes, initiates a cascade of detrimental cellular and molecular events that profoundly impact tissue repair. This includes the accelerated formation of advanced glycation end products (AGEs), which not only alter tissue structure but also contribute to inflammation and oxidative stress. These interconnected processes disrupt the normal physiological phases of wound repair, leading to compromised granulation tissue formation, reduced neovascularization, and impaired epithelialization, ultimately resulting in delayed wound closure. [1] Hyperglycemia is a principal driver of oxidative stress in diabetic wounds, overwhelming the endogenous antioxidant defense systems. The excess production of reactive oxygen species (ROS) inflicts damage upon cellular components vital for healing, such as fibroblasts and endothelial cells, thereby hindering their proliferative and migratory capabilities and impairing their capacity to synthesize extracellular matrix. This oxidative damage is intrinsically linked to dysregulated inflammatory responses, fostering a chronic inflammatory environment that perpetuates tissue damage and impedes the progression of healing. [2] Advanced glycation end products (AGEs) accumulate in diabetic tissues due to the non-enzymatic reaction between glucose and proteins and lipids. These modified molecules contribute to wound healing impairment by cross-linking collagen, which increases tissue stiffness and reduces cell mobility. AGEs also trigger inflammatory signaling pathways, notably through the receptor for advanced glycation end products (RAGE), further contributing to a pro-inflammatory milieu that hinders effective tissue regeneration and remodeling. [3] The process of angiogenesis, essential for supplying oxygen and nutrients to the wound, is significantly impaired in diabetes. Hyperglycemia and its downstream effects, including resistance to growth factors like VEGF, impede the ability of endothelial cells to proliferate, migrate, and form new blood vessels. This reduced vascularity leads to chronic hypoxia within the wound bed, slowing down all aspects of the healing cascade and increasing the risk of tissue necrosis. [4] Diabetic neuropathy, a common complication that affects nerve function, profoundly impacts wound healing by diminishing protective sensation and altering autonomic nerve regulation. The lack of sensation increases the likelihood of unnoticed injuries and repetitive trauma to the extremities, further compromising wound integrity. Impaired autonomic control can lead to poor regulation of local blood flow and reduced sweat gland function, resulting in dry, brittle skin that is prone to cracking and ulceration. [5] The inflammatory response in diabetic wounds often becomes chronic and unresolved, hindering the transition from the inflammatory phase to the proliferative phase of healing. While acute inflammation is crucial for clearing debris and initiating repair, sustained inflammation in diabetes leads to ongoing tissue damage. Dysfunctional immune cells, particularly neutrophils and macrophages, contribute to this prolonged inflammatory state, failing to effectively clear necrotic tissue and release essential growth factors needed for regeneration. [6] Extracellular matrix (ECM) remodeling is a critical aspect of wound healing, involving the synthesis, deposition, and degradation of ECM components. In diabetic wounds, fibroblasts exhibit altered ECM production and reduced functional capacity. Moreover, an increase in the activity of matrix metalloproteinases (MMPs), enzymes responsible for ECM degradation, leads to excessive breakdown of the provisional matrix, preventing the formation of a stable scaffold for cell migration and tissue organization, thus impeding wound closure. [7] Peripheral artery disease (PAD), a frequent complication of diabetes, severely compromises wound healing by restricting blood supply to the affected tissues. Atherosclerosis narrows arterial lumens, leading to chronic ischemia and inadequate delivery of oxygen, nutrients, and immune cells to the wound site. This compromised perfusion makes diabetic wounds in patients with PAD highly susceptible to non-healing, infection, and potentially limb loss. [8] Therapeutic strategies for managing diabetic wounds are diverse and target the multifaceted nature of the disease's impact on healing. Strict glycemic control remains a cornerstone of management. Beyond this, interventions aimed at mitigating oxidative stress, modulating chronic inflammation, promoting neovascularization, and improving tissue perfusion are vital. Advanced wound care techniques, including negative pressure wound therapy, hyperbaric oxygen therapy, and the use of growth factors, are often employed to support the healing process. [9] The role of the skin microbiome in the context of diabetic wound healing is an emerging and complex area of research. Alterations in the microbial composition of the skin, combined with the impaired immune response characteristic of diabetes, can foster an environment conducive to chronic wound infections and delayed healing. Investigating the microbial ecology of diabetic wounds and exploring strategies to restore a balanced microbiome may offer promising new therapeutic avenues. [10]
Diabetes mellitus profoundly impairs wound healing through multifaceted mechanisms. Hyperglycemia leads to advanced glycation end products (AGEs), oxidative stress, and chronic inflammation, disrupting granulation tissue formation, angiogenesis, and re-epithelialization. Comorbidities like neuropathy and peripheral artery disease further exacerbate these issues by reducing sensation and blood flow. Oxidative stress damages key cells, hindering their ability to repair tissue. AGEs stiffen collagen and promote inflammation. Impaired angiogenesis reduces nutrient and oxygen delivery. Neuropathy decreases sensation, increasing injury risk, and autonomic dysfunction affects blood flow. Chronic inflammation, driven by dysfunctional immune cells, stalls the healing process. Disrupted extracellular matrix turnover and increased matrix metalloproteinase activity prevent proper tissue scaffolding. Peripheral artery disease causes ischemia, leading to non-healing wounds and potential amputation. Therapeutic strategies focus on glycemic control, reducing oxidative stress and inflammation, promoting angiogenesis, and improving perfusion. Advanced wound care modalities are also employed. The role of the microbiome in diabetic wound healing is an area of ongoing research.
None
None
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report
